Personalized AZithromycin/metronidAZole Therapy in Pediatric Crohn's Disease (CD)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
This is a multi-center, randomized, controlled open-label add-on design trial pilot study to evaluate the efficacy of personalized adjunctive antibiotic (azithromycin + metronidazole) therapy in pediatric subjects with mild to moderate Crohn\'s disease (CD) who have a microbiome profile associated with increased risk of early relapse. This an add-on design trial for subjects already receiving standard of care therapy to induce remission; there will be no placebos.
Epistemonikos ID: 320247bed96524e9d56e522a56c36958029e8d86
First added on: May 06, 2024